Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Patient Satisfaction With GLASH VISTA™ (Bimatoprost 0.03%) in the Treatment of Eyelash Hypotrichosis in Japan

NCT02505776 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT02505776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02505776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Patient Satisfaction With GLASH VISTA™ (Bimatoprost 0.03%) in the Treatment of Eyelash Hypotrichosis in Japan
Lead sponsor
Allergan
Phase
Observational
Overall status
Completed
Start date
December 8, 2014
Completion date
May 21, 2018
Enrollment
1,699 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

eyelash hypotrichosis